Hikma Pharmaceuticals (HKMPF)
PNK: HKMPF
· Real-Time Price · USD
26.93
0.73 (2.80%)
At close: May 07, 2025, 12:33 PM
2.80% (1D)
Bid | 25.87 |
Market Cap | 5.94B |
Revenue (ttm) | 3.13B |
Net Income (ttm) | 359M |
EPS (ttm) | 1.61 |
PE Ratio (ttm) | 16.73 |
Forward PE | n/a |
Analyst | n/a |
Ask | 27.67 |
Volume | 132 |
Avg. Volume (20D) | 243 |
Open | 26.93 |
Previous Close | 26.20 |
Day's Range | 26.93 - 26.93 |
52-Week Range | 22.56 - 28.91 |
Beta | 0.63 |
About HKMPF
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HKMPF
Website n/a

3 months ago · seekingalpha.com
Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Pre-Recorded (Transcript)Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q4 2024 Results Conference Call February 26, 2025 2:00 AM ET Company Participants Riad Mishlawi - Chief Executive Officer Khalid Nabilsi - Chief Financial Offic...

3 months ago · proactiveinvestors.co.uk
Hikma shares fall 5% as stock succumbs to profit taking after strong results and outlook statementHikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares fell five per cent in early trading as investors took profits despite the company reporting strong results and an upbeat outlook for 2025. Revenue...